185 related articles for article (PubMed ID: 2579087)
1. Mechanism of the inhibitory action of dopamine and somatostatin on prolactin secretion from human lactotrophs in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 Mar; 60(3):599-606. PubMed ID: 2579087
[TBL] [Abstract][Full Text] [Related]
2. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
3. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
4. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
[TBL] [Abstract][Full Text] [Related]
5. Effects of somatostatin and urotensin II on tilapia pituitary prolactin release and interactions between somatostatin, osmotic pressure Ca++, and adenosine 3',5'-monophosphate in prolactin release in vitro.
Grau EG; Nishioka RS; Bern HA
Endocrinology; 1982 Mar; 110(3):910-5. PubMed ID: 6173210
[TBL] [Abstract][Full Text] [Related]
6. Adenosine 3',5'-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization.
Schettini G; Cronin MJ; MacLeod RM
Endocrinology; 1983 May; 112(5):1801-7. PubMed ID: 6299710
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
Bjøro T; Ostberg BC; Sand O; Torjesen PA; Penman E; Gordeladze JO; Iversen JG; Gautvik KM; Haug E
Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
[TBL] [Abstract][Full Text] [Related]
8. Low concentrations of dopamine increase cytosolic calcium in lactotrophs.
Burris TP; Freeman ME
Endocrinology; 1993 Jul; 133(1):63-8. PubMed ID: 8391429
[TBL] [Abstract][Full Text] [Related]
9. Dopamine inhibits prolactin secretion stimulated by the calcium channel agonist Bay-K-8644 through a pertussis toxin-sensitive G protein in anterior pituitary cells.
Enjalbert A; Musset F; Chénard C; Priam M; Kordon C; Heisler S
Endocrinology; 1988 Jul; 123(1):406-12. PubMed ID: 2454806
[TBL] [Abstract][Full Text] [Related]
10. The role of adenosine 3',5'-monophosphate in dopaminergic inhibition of prolactin release in anterior pituitary cells.
Tam SW; Dannies PS
Endocrinology; 1981 Aug; 109(2):403-8. PubMed ID: 6166464
[TBL] [Abstract][Full Text] [Related]
11. Dopamine inhibits prolactin release when cyclic adenosine 3',5'-monophosphate levels are elevated.
Delbeke D; Scammell JG; Martinez-Campos A; Dannies PS
Endocrinology; 1986 Apr; 118(4):1271-7. PubMed ID: 3004906
[TBL] [Abstract][Full Text] [Related]
12. Dopamine decreases 7315a tumor cell prolactin release induced by calcium mobilization.
Judd AM; Koike K; Schettini G; Login IS; Hewlett EL; Yasumoto T; MacLeod RM
Endocrinology; 1985 Sep; 117(3):1215-21. PubMed ID: 3926467
[TBL] [Abstract][Full Text] [Related]
13. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.
Le Dafniet M; Lefebvre P; Barret A; Mechain C; Feinstein MC; Brandi AM; Peillon F
J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264
[TBL] [Abstract][Full Text] [Related]
14. In vitro studies on basal and stimulated prolactin release by rat anterior pituitary: a possible role for calmodulin.
Schettini G; Judd AM; MacLeod RM
Endocrinology; 1983 Jan; 112(1):64-70. PubMed ID: 6291923
[TBL] [Abstract][Full Text] [Related]
15. Effect of dopamine withdrawal on activation of adenylate cyclase and phospholipase C in enriched lactotrophs.
Martinez de la Escalera G; Weiner RI
Endocrinology; 1988 Sep; 123(3):1682-7. PubMed ID: 2456918
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
Delbeke D; Dannies PS
Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
[TBL] [Abstract][Full Text] [Related]
17. Dependence of electrical activity and calcium influx-controlled prolactin release on adenylyl cyclase signaling pathway in pituitary lactotrophs.
Gonzalez-Iglesias AE; Jiang Y; Tomić M; Kretschmannova K; Andric SA; Zemkova H; Stojilkovic SS
Mol Endocrinol; 2006 Sep; 20(9):2231-46. PubMed ID: 16645040
[TBL] [Abstract][Full Text] [Related]
18. Is calcium or cyclic AMP involved in the inhibitory effect on pituitary hormone secretion of the tripeptide aldehyde proteinase inhibitors?
Makara GB; Szentendrei T; Rappay G
Mol Cell Endocrinol; 1987 Jul; 52(1-2):63-9. PubMed ID: 2442048
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
Wang J; Ciofi P; Crowley WR
Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
[TBL] [Abstract][Full Text] [Related]
20. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
